FemTherapeutics is a biotechnology company focused on developing novel therapeutics for female reproductive health. The company leverages its proprietary drug delivery platform to address unmet medical needs in women's health, with an emphasis on non-hormonal treatments for conditions like uterine fibroids and endometriosis.

FemTherapeutics

FemTherapeutics is a medical device company developing “Invisalign for Gynaecology”. Leveraging artificial intelligence and 3D Printing, our gynaecology platform offers patient-specific intra-vaginal devices for common pelvic health conditions. Our first product is a custom pessary for the management of Pelvic Organ Prolapse and Stress Urinary Incontinence, which affects 50% of women during their lifetime. FemTherapeutics is building the infrastructure to allow expansion into other pelvic health categories including menstruation and sexual wellness, labor and delivery, oncology, and more. 

Ministère de l'Économie et de l'Innovation

Centech

Fonds de solidarité FTQ

Natural Sciences and Engineering Research Council of Canada (NSERC)

McGill University

Mitacs

Montréal inc.

Mouvement des accelerateurs d'innovation du Quebec

National Research Council Canada

Investissement Quebec

SheBoot

The 51 Ventures

2048 Ventures

FemTherapeutics Inc.

COM:FEMTHERAPEUTICS

FemTherapeutics

Financials Not Available